IRF8

Source: Wikipedia, the free encyclopedia.
IRF8
Identifiers
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_002163
NM_001363907
NM_001363908

NM_001301811
NM_008320

RefSeq (protein)

NP_002154
NP_001350836
NP_001350837

NP_001288740
NP_032346

Location (UCSC)Chr 16: 85.9 – 85.92 MbChr 8: 121.46 – 121.48 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Interferon regulatory factor 8 (IRF8) also known as interferon consensus sequence-binding protein (ICSBP), is a

myeloid cell maturation including the decision for a common myeloid progenitor (CMP) to differentiate into a monocyte
precursor cell.

Function

Interferon Consensus Sequence-binding protein (ICSBP) is a transcription factor of the interferon regulatory factor (IRF) family. Proteins of this family are composed of a conserved DNA-binding domain in the N-terminal region and a divergent C-terminal region that serves as the regulatory domain. The IRF family proteins bind to the IFN-stimulated response element (ISRE) and regulate expression of genes stimulated by type I IFNs, namely IFN-α and IFN-β. IRF family proteins also control expression of IFN-α and IFN-β-regulated genes that are induced by viral infection.[5]

Knockout studies

IFN-producing cells (mIPCs) were absent in all lymphoid organs from ICSBP

Clinical significance

In myeloid cells, IRF8 regulates the expression of

Bax and Fas to regulate apoptosis.[9] In chronic myelogenous leukemia (CML), IRF8 regulates acid ceramidase to mediate CML apoptosis.[10]

IRF8 is highly expressed in myeloid cells and was originally identified in as a critical lineage-specific transcription factor for myeloid cell differentiation,

hematopoietic cancer cells, albeit at a lower level. Furthermore, IRF8 can also be up-regulated by IFN-γ in non-hemotopoietic cells. IRF8 mediates the expression of Fas, Bax, FLIP, Jak1 and STAT1 to mediate apoptosis in non-hemotopoietic cancer cells.[12][13][14]

Analysis of human cancer genomics database revealed that IRF8 is not significantly focally amplified across the entire dataset of 3131 tumors, but is significantly focally deleted across the entire dataset of 3131 tumors, suggesting that IRF8 is potentially a

suggesting that these cells might use DNA methylation to silence IRF8 expression to advance the disease.

Interactions

IRF8 has been shown to

See also

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000140968Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000041515Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: IRF8 interferon regulatory factor 8".
  6. ]
  7. .
  8. .
  9. .
  10. .
  11. .
  12. .
  13. .
  14. ^ .
  15. ^ "Tumorscape". The Broad Institute. Archived from the original on 2012-04-14. Retrieved 2012-07-05.
  16. PMID 19074829
    .
  17. .
  18. .
  19. .

Illustrations

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

This page is based on the copyrighted Wikipedia article: IRF8. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy